| PD-L1 expression is regulated by both DNA methylation and NF-kB during EMT signaling in non-small cell lung carcinoma A Asgarova, K Asgarov, Y Godet, P Peixoto, A Nadaradjane, ... Oncoimmunology 7 (5), e1423170, 2018 | 188 | 2018 |
| Immunoregulation and Clinical Implications of ANGPT2/TIE2+ M-MDSC Signature in Non–Small Cell Lung Cancer E Lauret Marie Joseph, C Laheurte, M Jary, L Boullerot, K Asgarov, ... Cancer immunology research 8 (2), 268-279, 2020 | 35 | 2020 |
| Molecular description of ANGPT2 associated colorectal carcinoma M Jary, R Hasanova, A Vienot, K Asgarov, R Loyon, C Tirole, A Bouard, ... International Journal of Cancer 147 (7), 2007-2018, 2020 | 21 | 2020 |
| CD8+ CD226high T cells in liver metastases dictate the prognosis of colorectal cancer patients treated with chemotherapy and radical surgery J Viot, S Abdeljaoued, A Vienot, E Seffar, L Spehner, A Bouard, K Asgarov, ... Cellular & molecular immunology 20 (4), 365-378, 2023 | 12 | 2023 |
| A new anti-mesothelin antibody targets selectively the membrane-associated form K Asgarov, J Balland, C Tirole, A Bouard, V Mougey, D Ramos, A Barroso, ... MAbs 9 (3), 567-577, 2017 | 11 | 2017 |
| SALL4‐related gene signature defines a specific stromal subset of pancreatic ductal adenocarcinoma with poor prognostic features A Vienot, F Monnien, C Truntzer, V Mougey, A Bouard, JR Pallandre, ... Molecular Oncology 17 (7), 1356-1378, 2023 | 7 | 2023 |
| SO-20 stanniocalcin 1 (STC1) in patients with refractory colorectal cancer (CRC) treated with regorafenib: an exploratory analysis of the CORRECT trial A Vienot, D Vernerey, A Bouard, E Klajer, K Asgarov, S Kim, ... Annals of Oncology 33, S365, 2022 | 4 | 2022 |
| Development of Anti-LRRC15 Small Fragments for Imaging Purposes Using a Phage-Display ScFv Approach PE Baurand, J Balland, C Reynas, M Ramseyer, D Vivier, PS Bellaye, ... International Journal of Molecular Sciences 23 (20), 12677, 2022 | 3 | 2022 |
| Predictive biomarkers and specific immune responses of COVID-19 mRNA vaccine in patients with cancer: prospective results from the CACOV-VAC trial L Spehner, E Orillard, A Falcoz, Q Lepiller, A Bouard, H Almotlak, S Kim, ... BMJ Oncology 2 (1), 2023 | 1 | 2023 |
| Development of more precise and efficient antibodies for cancer targeting: membrane associated form specific anti-mesothelin antibodies and CAR as an example K Asgarov Université de Franche-Comté, 2016 | | 2016 |
| Stanniocalcin 1 (STC1) in patients with refractory colorectal cancer treated with regorafenib: An exploratory analysis of the CORRECT trial A Vienot, D Vernerey, A Bouard, E Klajer, K Asgarov, S Kim, ... Liver 312, 48, 0 | | |
